UnitedHealth Group Stock Surges on Strong Q2 Earnings and Raised Guidance
UnitedHealth Group's stock price has surged to near $400 due to strong second-quarter earnings and revised full-year guidance. The company reported adjusted earnings per share of $6.38, exceeding Wall Street estimates by 31%. This represents a significant beat in earnings expectations.
The raised guidance for the full year 2026 is a range of $19.50 to $20.00, compared to prior estimates. Analysts now expect UnitedHealth Group to post around $19.82 in earnings per share for the full fiscal year 2026, which sits in the upper half of management's outlook range.
Operational changes, such as removing approximately 1,700 procedures from prior authorization requirements, are also contributing to the company's momentum. This move aims to reduce administrative burden and improve patient access to care.